Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

[Mutations in Hemagglutinin and Polymerase Alter the Virulence of Pandemic A(H1N1) Influenza Virus].

Gambaryan AS, Lomakina NF, Boravleva EY, Mochalova LV, Sadykova GK, Prilipov AG, Matrosovich TY, Matrosovich MN.

Mol Biol (Mosk). 2018 Jul-Aug;52(4):644-658. doi: 10.1134/S0026898418040055. Russian.

2.

Receptor-binding properties of influenza viruses isolated from gulls.

Gambaryan AS, Matrosovich TY, Boravleva EY, Lomakina NF, Yamnikova SS, Tuzikov AB, Pazynina GV, Bovin NV, Fouchier RAM, Klenk HD, Matrosovich MN.

Virology. 2018 Sep;522:37-45. doi: 10.1016/j.virol.2018.07.004. Epub 2018 Jul 12.

3.

Immunization with live nonpathogenic H5N3 duck influenza virus protects chickens against highly pathogenic H5N1 virus.

Gambaryan AS, Boravleva EY, Lomakina NF, Kropotkina EA, Gordeychuk IV, Chvala IA, Drygin VV, Klenk HD, Matrosovich MN.

Acta Virol. 2016;60(3):316-27.

PMID:
27640442
4.

What adaptive changes in hemagglutinin and neuraminidase are necessary for emergence of pandemic influenza virus from its avian precursor?

Gambaryan AS, Matrosovich MN.

Biochemistry (Mosc). 2015 Jul;80(7):872-80. doi: 10.1134/S000629791507007X. Review.

5.

Solid-phase assays of receptor-binding specificity.

Matrosovich MN, Gambaryan AS.

Methods Mol Biol. 2012;865:71-94. doi: 10.1007/978-1-61779-621-0_5.

PMID:
22528154
6.

Receptor-binding profiles of H7 subtype influenza viruses in different host species.

Gambaryan AS, Matrosovich TY, Philipp J, Munster VJ, Fouchier RA, Cattoli G, Capua I, Krauss SL, Webster RG, Banks J, Bovin NV, Klenk HD, Matrosovich MN.

J Virol. 2012 Apr;86(8):4370-9. doi: 10.1128/JVI.06959-11. Epub 2012 Feb 15.

7.

Altered receptor specificity and fusion activity of the haemagglutinin contribute to high virulence of a mouse-adapted influenza A virus.

Koerner I, Matrosovich MN, Haller O, Staeheli P, Kochs G.

J Gen Virol. 2012 May;93(Pt 5):970-9. doi: 10.1099/vir.0.035782-0. Epub 2012 Jan 18.

PMID:
22258863
8.

Aprotinin, a protease inhibitor, suppresses proteolytic activation of pandemic H1N1v influenza virus.

Zhirnov OP, Matrosovich TY, Matrosovich MN, Klenk HD.

Antivir Chem Chemother. 2011 Mar 7;21(4):169-74. doi: 10.3851/IMP1715. Erratum in: Antivir Chem Chemother. 2011;21(6):245.

PMID:
21602614
9.

6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry.

Gambaryan AS, Tuzikov AB, Pazynina GV, Desheva JA, Bovin NV, Matrosovich MN, Klimov AI.

Virol J. 2008 Jul 24;5:85. doi: 10.1186/1743-422X-5-85.

10.

[Different receptor specificity of influence viruses from ducks and chickens and its reflection in the composition of sialosides on host cells and mucins].

Gambarian AS, Marinina VP, Solodar' TA, Bovin NV, Tuzikov AB, Pazynina GV, Iamnikova SS, L'vov DK, Klimov AI, Matrosovich MN.

Vopr Virusol. 2006 Jul-Aug;51(4):24-32. Russian.

PMID:
16929595
11.

Polymer-bound 6' sialyl-N-acetyllactosamine protects mice infected by influenza virus.

Gambaryan AS, Boravleva EY, Matrosovich TY, Matrosovich MN, Klenk HD, Moiseeva EV, Tuzikov AB, Chinarev AA, Pazynina GV, Bovin NV.

Antiviral Res. 2005 Dec;68(3):116-23. Epub 2005 Sep 9.

PMID:
16214231
12.

Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.

Yen HL, Herlocher LM, Hoffmann E, Matrosovich MN, Monto AS, Webster RG, Govorkova EA.

Antimicrob Agents Chemother. 2005 Oct;49(10):4075-84.

13.

Receptor-binding properties of swine influenza viruses isolated and propagated in MDCK cells.

Gambaryan AS, Karasin AI, Tuzikov AB, Chinarev AA, Pazynina GV, Bovin NV, Matrosovich MN, Olsen CW, Klimov AI.

Virus Res. 2005 Dec;114(1-2):15-22. Epub 2005 Jul 5.

PMID:
15996787
14.

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium.

Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD.

J Virol. 2004 Nov;78(22):12665-7.

15.

H5N1 chicken influenza viruses display a high binding affinity for Neu5Acalpha2-3Galbeta1-4(6-HSO3)GlcNAc-containing receptors.

Gambaryan AS, Tuzikov AB, Pazynina GV, Webster RG, Matrosovich MN, Bovin NV.

Virology. 2004 Sep 1;326(2):310-6.

16.

Human and avian influenza viruses target different cell types in cultures of human airway epithelium.

Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD.

Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4620-4. Epub 2004 Mar 15.

17.

Differences between HA receptor-binding sites of avian influenza viruses isolated from Laridae and Anatidae.

Yamnikova SS, Gambaryan AS, Tuzikov AB, Bovin NV, Matrosovich MN, Fedyakina IT, Grinev AA, Blinov VM, Lvov DK, Suarez DL, Swayne DE.

Avian Dis. 2003;47(3 Suppl):1164-8.

PMID:
14575135
18.

Differences between influenza virus receptors on target cells of duck and chicken and receptor specificity of the 1997 H5N1 chicken and human influenza viruses from Hong Kong.

Gambaryan AS, Tuzikov AB, Bovin NV, Yamnikova SS, Lvov DK, Webster RG, Matrosovich MN.

Avian Dis. 2003;47(3 Suppl):1154-60.

PMID:
14575133
19.

[The effect of losing glycosylation sites near the receptor-binding region on the receptor phenotype of the human influenza virus H1N1].

Marinina VP, Gambarian AS, Bovin NV, Tuzikov AB, Shilov AA, Sinitsyn BV, Matrosovich MN.

Mol Biol (Mosk). 2003 May-Jun;37(3):550-5. Russian.

PMID:
12815964
20.

Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection.

Gambaryan AS, Tuzikov AB, Chinarev AA, Juneja LR, Bovin NV, Matrosovich MN.

Antiviral Res. 2002 Jul;55(1):201-5.

PMID:
12076764
21.

[Differences in receptor specificity between the influenza A viruses isolated from the duck, chicken, and human].

Gambarian AS, Iamnikova SS, L'vov DK, Robertson JS, Webster RG, Matrosovich MN.

Mol Biol (Mosk). 2002 May-Jun;36(3):542-9. Russian.

PMID:
12068641
22.

H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity.

Matrosovich MN, Krauss S, Webster RG.

Virology. 2001 Mar 15;281(2):156-62.

23.

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.

Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG.

J Infect Dis. 2001 Feb 15;183(4):523-31. Epub 2001 Jan 11.

PMID:
11170976
24.

Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.

Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y.

J Virol. 2000 Jul;74(13):6015-20.

25.

[The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren].

El'shina GA, Gorbunov MA, Bektimirov TA, Lonskaia NI, Pavlova LI, Nikul'shin AA, Khaitov RM, Nekrasov AV, Ivanova AS, Matrosovich MN, Puchkova NG.

Zh Mikrobiol Epidemiol Immunobiol. 2000 Mar-Apr;(2):50-4. Russian.

PMID:
10808574
26.

Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes.

Kaverin NV, Matrosovich MN, Gambaryan AS, Rudneva IA, Shilov AA, Varich NL, Makarova NV, Kropotkina EA, Sinitsin BV.

Virus Res. 2000 Feb;66(2):123-9.

PMID:
10725545
27.

Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells.

Govorkova EA, Matrosovich MN, Tuzikov AB, Bovin NV, Gerdil C, Fanget B, Webster RG.

Virology. 1999 Sep 15;262(1):31-8.

28.

Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses.

Gambaryan AS, Robertson JS, Matrosovich MN.

Virology. 1999 Jun 5;258(2):232-9.

29.

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.

Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG.

J Infect Dis. 1998 Nov;178(5):1257-62.

PMID:
9780244
31.

Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs.

Gambaryan AS, Marinina VP, Tuzikov AB, Bovin NV, Rudneva IA, Sinitsyn BV, Shilov AA, Matrosovich MN.

Virology. 1998 Aug 1;247(2):170-7.

32.

[Evaluation of the effectiveness of influenza trivalent polymer subunit vaccine "Grippol"].

El'shina GA, Gorbunov MA, Shervarli VI, Lonskaia NI, Pavlova LI, Khaitov RM, Nekrasov AV, Ivanova AS, Matrosovich MN, Puchkova NG, Belashev VP, Malinovskiĭ AA.

Zh Mikrobiol Epidemiol Immunobiol. 1998 May-Jun;(3):40-3. Russian.

PMID:
9700880
33.

Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.

Matrosovich MN, Gambaryan AS, Teneberg S, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, Karlsson KA.

Virology. 1997 Jun 23;233(1):224-34.

35.

[The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].

El'shina GA, Gorbunov MA, Shervarli VI, Lonskaia NI, Khaitov RM, Nekrasov AV, Ivanova AS, Matrosovich MN, Puchkova NG, Pavlova LI, Malinovskiĭ AA.

Voen Med Zh. 1997 Feb;318(2):47-9. Russian. No abstract available.

PMID:
9148581
36.

Monovalent and polymeric 5N-thioacetamido sialosides as tightly-bound receptor analogs of influenza viruses.

Tuzikov AB, Byramova NE, Bovin NV, Gambaryan AS, Matrosovich MN.

Antiviral Res. 1997 Jan;33(2):129-34.

PMID:
9021054
37.

[The trivalent polymer-subunit influenza vaccine Grippol studied in a controlled epidemiological trial (1)].

El'shina GA, Masalin IuM, Shervali VI, Gorbunov MA, Lonskaia NI, Agafonova LV, Khaitov RM, Nekrasov AV, Ivanova AS, Matrosovich MN, Puchkova NG.

Voen Med Zh. 1996 Aug;317(8):57-60. Russian. No abstract available.

PMID:
9036650
38.

Human influenza virus recognition of sialyloligosaccharides.

Gambaryan AS, Piskarev VE, Yamskov IA, Sakharov AM, Tuzikov AB, Bovin NV, Nifant'ev NE, Matrosovich MN.

FEBS Lett. 1995 Jun 5;366(1):57-60.

39.

Synthetic polymeric inhibitors of influenza virus receptor-binding activity suppress virus replication.

Mochalova LV, Tuzikov AB, Marinina VP, Gambaryan AS, Byramova NE, Bovin NV, Matrosovich MN.

Antiviral Res. 1994 Apr;23(3-4):179-90.

PMID:
7519002
40.

Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides.

Matrosovich MN, Gambaryan AS, Tuzikov AB, Byramova NE, Mochalova LV, Golbraikh AA, Shenderovich MD, Finne J, Bovin NV.

Virology. 1993 Sep;196(1):111-21.

PMID:
8356788
41.

A solid-phase enzyme-linked assay for influenza virus receptor-binding activity.

Gambaryan AS, Matrosovich MN.

J Virol Methods. 1992 Sep;39(1-2):111-23.

PMID:
1430058
42.

Influenza viruses differ in recognition of 4-O-acetyl substitution of sialic acid receptor determinant.

Matrosovich MN, Gambaryan AS, Chumakov MP.

Virology. 1992 Jun;188(2):854-8.

PMID:
1374985
43.

[Use of highly purified subvirion trivalent flue vaccine ("Grippovak") in groups with a high risk of complications].

Chumakov MP, Beregovskiĭ NA, Linev MB, Reĭzin FN, Malyshkina LP, Matrosovich MN, Mart'ianova LI, Piatnitskaia AF, Solov'eva MV.

Zh Mikrobiol Epidemiol Immunobiol. 1992 Mar;(3):55-7. Russian.

PMID:
1509852
44.

Recognition by human A and B influenza viruses of 8- and 7-carbon analogues of sialic acid modified in the polyhydroxyl side chain.

Matrosovich MN, Gambaryan AS, Reizin FN, Chumakov MP.

Virology. 1991 Jun;182(2):879-82.

PMID:
1708935
45.

[A new prospective vaccine against tick-borne encephalitis].

Chumakov MP, Rubin SG, Semashko IV, Karavanov AS, Avdeeva LI, Gagarina AV, Gambarian AS, Matrosovich MN, Mart'ianova LI, Mironova LL, et al.

Zh Mikrobiol Epidemiol Immunobiol. 1991 Jan;(1):36-40. Russian. No abstract available.

PMID:
1858468
46.

Synthetic polymeric sialoside inhibitors of influenza virus receptor-binding activity.

Matrosovich MN, Mochalova LV, Marinina VP, Byramova NE, Bovin NV.

FEBS Lett. 1990 Oct 15;272(1-2):209-12.

48.

[Immunoenzyme analysis of "neo-ovalbumin" substrate admixtures in inactivated influenza vaccines].

Matrosovich MN, Gambarian AS, Kisin VV, Marinina VP, Mart'ianova LI.

Vopr Virusol. 1989 Jul-Aug;34(4):491-5. Russian. No abstract available.

PMID:
2686165
49.

[Can formaldehyde, merthiolate and other vaccine components enhance the anaphylactogenicity of ovalbumin present in inactivated influenza vaccines?].

Reĭzin FN, Matrosovich MN, Chumakov MP, Mart'ianova LI.

Vopr Virusol. 1987 Sep-Oct;32(5):615-6. Russian. No abstract available.

PMID:
3433718
50.

[Affinity chromatography of serum albumin on synthetic polymeric adsorbents].

Plate NA, Matrosovich MN.

Dokl Akad Nauk SSSR. 1976;229(2):496-9. Russian. No abstract available.

PMID:
971662

Supplemental Content

Loading ...
Support Center